BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 110332)

  • 1. A new approach to anti-inflammatory drugs.
    Higgs GA; Flower RJ; Vane JR
    Biochem Pharmacol; 1979 Jun; 28(12):1959-61. PubMed ID: 110332
    [No Abstract]   [Full Text] [Related]  

  • 2. Garden rue inhibits the arachidonic acid pathway, scavenges free radicals, and elevates FRAP: role in inflammation.
    Kataki MS; Kakoti BB; Bhuyan B; Rajkumari A; Rajak P
    Chin J Nat Med; 2014 Mar; 12(3):172-9. PubMed ID: 24702802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.
    Whittle BJ; Higgs GA; Eakins KE; Moncada S; Vane JR
    Nature; 1980 Mar; 284(5753):271-3. PubMed ID: 6767192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
    Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
    Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence in the rat of counter-irritation by turpentine on the leukocyte content of exudates induced by sponge implants].
    Deflandre E; Damas J
    J Pharmacol; 1986; 17(2):155-62. PubMed ID: 3091943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new antiinflammatory compound, timegadine (N-cyclohexyl-N"-4-[2-methylquinolyl]-N'-2-thiazolylguanidine), which inhibits both prostaglandin and 12-hydroxyeicosatetraenoic acid (12-HETE) formation.
    Ahnfelt-Rønne I; Arrigoni-Martelli E
    Biochem Pharmacol; 1980 Dec; 29(24):3265-9. PubMed ID: 6783045
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.
    Smith JB; Dangelmaier C; Mauco G
    Biochim Biophys Acta; 1985 Jul; 835(2):344-51. PubMed ID: 3924113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-inflammatory drugs on rat paw oedema and leukocyte migration.
    Engler H; Szelenyi I
    Int J Tissue React; 1985; 7(2):133-5. PubMed ID: 2411677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins, leucocytes and non-steroidal anti-inflammatory drugs.
    Di Rosa M
    Pol J Pharmacol Pharm; 1974; 26(1):25-36. PubMed ID: 4134228
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.
    Robak J; Duniec Z
    Biochem Pharmacol; 1982 Jun; 31(11):1955-9. PubMed ID: 6810898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antirheumatics and inhibitors of cyclooxygenase, lipoxygenases and thromboxane synthetase on cobra venom factor rat paw edema.
    Otto M; Bekemeier H; Hirschelmann R
    Biomed Biochim Acta; 1984; 43(8-9):S291-5. PubMed ID: 6440543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen.
    Adams SS; Burrows CA; Skeldon N; Yates DB
    Curr Med Res Opin; 1977; 5(1):11-6. PubMed ID: 410589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets.
    Blackwell GJ; Flower RJ
    Prostaglandins; 1978 Sep; 16(3):417-25. PubMed ID: 103141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
    Zarnack S; Bekemeier H; Giessler AJ
    Pharmazie; 1988 May; 43(5):337-8. PubMed ID: 3140256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and the anti-inflammatory activities of aspirin and sodium salicylate.
    Smith MJ; Ford-Hutchinson AW; Elliott PN
    J Pharm Pharmacol; 1975 Jul; 27(7):473-8. PubMed ID: 239150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of cyclooxygenase and lipoxygenase by 2-acetylthiophene 2-thiazolylhydrazone (CBS-1108) and effect on leukocyte migration in vivo.
    Bertez C; Miquel M; Coquelet C; Sincholle D; Bonne C
    Biochem Pharmacol; 1984 Jun; 33(11):1757-62. PubMed ID: 6428415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
    Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
    Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.